You just read:

Regeneron and Sanofi to Lower Net Price of Praluent® (alirocumab) Injection in Exchange for Straightforward, More Affordable Patient Access for Express Scripts Patients

News provided by

Regeneron Pharmaceuticals, Inc.

May 01, 2018, 06:59 ET